Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Livingston

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
BMJ Open|September 9, 2019
Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomesAdrian Heald, Mark Davies, Mike Stedman, et al.
International Journal of Clinical Practice|April 2, 2021
Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high social deprivationMark Livingston, Aiden Plant, Simon Dunmore, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Endobronchial adenosine monophosphate challenge causes tachykinin release in the human airwayFionnuala Crummy, Mark Livingston, Joy E S Ardill, et al.
Clinical Endocrinology|January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadismAdrian H Heald, Michael Stedman, Martin Whyte, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes AuditAdrian H Heald, Mark Livingston, Nagaraj Malipatil, et al.
Annals of General Psychiatry|March 15, 2017
Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional studyAdrian Heald, John Pendlebury, Simon Anderson, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 14, 2017
Monitoring Thyroid Function in Patients on Levothyroxine. Assessment of Conformity to National Guidance and Variability in PracticeJonathan J Scargill, Mark Livingston, David Holland, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 25, 2018
Screening for Hypogonadism in Primary Healthcare: How to do this EffectivelyMark Livingston, Richard Jones, Geoff Hackett, et al.
Cardiovascular Endocrinology & Metabolism|June 26, 2023
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosisAdrian H Heald, Mike Stedman, Chris Daly, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
BMJ Open|September 9, 2019
Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomesAdrian Heald, Mark Davies, Mike Stedman, et al.
International Journal of Clinical Practice|April 2, 2021
Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high social deprivationMark Livingston, Aiden Plant, Simon Dunmore, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Endobronchial adenosine monophosphate challenge causes tachykinin release in the human airwayFionnuala Crummy, Mark Livingston, Joy E S Ardill, et al.
Clinical Endocrinology|January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadismAdrian H Heald, Michael Stedman, Martin Whyte, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes AuditAdrian H Heald, Mark Livingston, Nagaraj Malipatil, et al.
Annals of General Psychiatry|March 15, 2017
Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional studyAdrian Heald, John Pendlebury, Simon Anderson, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 14, 2017
Monitoring Thyroid Function in Patients on Levothyroxine. Assessment of Conformity to National Guidance and Variability in PracticeJonathan J Scargill, Mark Livingston, David Holland, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 25, 2018
Screening for Hypogonadism in Primary Healthcare: How to do this EffectivelyMark Livingston, Richard Jones, Geoff Hackett, et al.
Cardiovascular Endocrinology & Metabolism|June 26, 2023
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosisAdrian H Heald, Mike Stedman, Chris Daly, et al.
Pageof 6